| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |